
Telma CT 40/12.5 mg Tablet
Salt Composition: Telmisartan (40mg) + Chlorthalidone (12.5mg)
Expiry Date: 01/2028
Inclusive of all taxes
15 Tablet
About The Product
both of which help to control high blood pressure. Lowering blood pressure helps to reduce your risk of having a heart attack or a stroke in the future.
Description
Telma CT 40/12.5mg tablet is a prescription based medication. It is used to help control blood pressure in adults.
The medication contains two active ingredient is Telmisartan in (40mg) concentration and Chlorthalidone in (12.5mg) concentration. It belongs to the drug class of antihypertensive, specifically a combination of angiotensin II receptor blocker (ARB).
The medicine is used to belong to the high blood pressure by relaxing blood vessels and removing excess salt and water from the body. Dosage and duration should be correctly administered by the healthcare professional only.
Uses
- Manage high blood pressure
Side Effects
Telma CT 40/12.5mg tablet also causes various side effects, some are acute and some are mild. Always consult a healthcare professional before using any medication. Reach out to the doctor if any of the symptoms persist or worsen:
- Dizziness
- Headache
- Fatigue
- Increased urination
- Muscle cramps or weakness
- Low blood pressure symptoms
- Allergic reactions (e.g., swelling of the face, lips, tongue, or throat, difficulty breathing, rash)
- Severe dizziness
- Light headedness
- Fainting
- High potassium levels (muscle weakness, irregular heartbeat)
- Liver problems
How To Use
- Dose must be administered by healthcare professional only.
- Do not continue to the medication if any of the side effects persist.
- Taken Telma CT 40/12.5mg tablet with food or without food at the fixed time everyday to enhance the effectiveness of the medication.
- Do not crush, chew or break the tablet as this may affect the way the medicine works and increase the side effects.
How It Works
- Telma CT 40/12.5mg tablet contains two salts Telmisartan (40mg) and Chlorthalidone (12.5mg). Telmisartan and widens blood vessels, making it easier for blood to flow and the heart to pump.
- Chlorthalidone increases urine output which reduces fluid volume in the body and lowering blood pressure further. They work together and reduces strain on the heart and can help lower the risk of complications like heart attack and stroke.
Safety Advice
FAQs
Telma CT 40/12.5mg tablet manage high blood pressure in adults by helping relax blood vessels and removes excess fluid from the body.
References
- Sagarad, S. V., Kerure, S. B., Kumar, C., & Mr, R. (2013). The antihypertensive efficacy of chlorthalidone and telmisartan in Indian hypertensive patients who were uncontrolled with hydrochlorothiazide and telmisartan combination-A prospective and an open label study. Journal of Clinical and Diagnostic Research: JCDR, 7(4), 687. https://pubmed.ncbi.nlm.nih.gov/23730647/
- Sarkar, G., Gaikwad, V. B., Sharma, A., Halder, S. K., Kumar, D. A., Anand, J., ... & Mehta, S. (2022). Fixed-dose combination of metoprolol, telmisartan, and chlorthalidone for essential hypertension in adults with stable coronary artery disease: Phase III Study. Advances in Therapy, 39(2), 923-942. https://pubmed.ncbi.nlm.nih.gov/34918194/
- Surwase, B. H., Tapkir, A. S., Jadhav, S. B., & Chaudhari, P. D. (2013). Development and validation of RP-HPLC method for simultaneous estimation of telmisartan and chlorthalidone in bulk and tablet dosage form. Scholar Research Library, 5(1), 149-154. https://www.researchgate.net/publication/288810696_Development_and_validation_of_RP-HPLC_method_for_simultaneous_estimation_of_telmisartan_and_clorthalidone_in_bulk_and_tablet_dosage_form
- Cho, E. J., Kim, M. H., Kim, Y. H., Chang, K., Choi, D. J., Kang, W. C., ... & Kim, H. S. (2023). Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double‐blind, active‐controlled, multicenter phase 3 trial. The Journal of Clinical Hypertension, 25(9), 817-827. https://pubmed.ncbi.nlm.nih.gov/37614053/
- Sarkar, G., Gaikwad, V. B., Sharma, A., Halder, S. K., Kumar, D. A., Anand, J., ... & Mehta, S. (2022). Fixed-dose combination of metoprolol, telmisartan, and chlorthalidone for essential hypertension in adults with stable coronary artery disease: Phase III Study. Advances in Therapy, 39(2), 923-942. https://pubmed.ncbi.nlm.nih.gov/34918194/
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
